Brief: MedMira Inc Announces Development Of Rapid Antibody Test Prototype That Detects Presence Of Neutralizing Antibodies Against Sars-Cov-2 Virus
Jan 30 (Reuters) - MedMira Inc MIR.V :
* MEDMIRA INC- ANNOUNCES DEVELOPMENT OF A RAPID ANTIBODY
TEST
PROTOTYPE THAT DETECTS PRESENCE OF NEUTRALIZING ANTIBODIES
AGAINST SARS-COV-2 VIRUS
* MEDMIRA INC - AT THIS TIME, THERE IS NO GUARANTEE THAT
THIS
PRODUCT WILL MEET ALL REGULATORY REQUIREMENTS AND RECEIVE A
SUBSEQUENT REGULATORY APPROVAL
Source text for Eikon: ID:nGNX7byq3L
Further company coverage: MIR.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MedMira
See all newsSamsung Pay to stop working with Russia's Mir payment system from April 3
US targets Russia with hundreds of sanctions over Ukraine war, Navalny death (updated)
Motorcycling-Pirro to replace Bastianini at Ducati for Americas GP (updated)
Uzbekistan halts use of Russia's Mir payment cards (updated)
Uzbekistan halts use of Russia's Mir payment cards